Thyroid Cancer:
Thyroid cancer was first described at the end of the eighteenth cen tury. For one and a half centuries surgery remained the only effective therapeutic option for this cancer, until in 1946 radioiodine therapy was performed for the first time. Radioiodine therapy was brought to Germany 4 years later...
Gespeichert in:
Weitere Verfasser: | , |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Berlin, Heidelberg
Springer Berlin Heidelberg
2001
|
Schlagworte: | |
Online-Zugang: | UBR01 Volltext |
Zusammenfassung: | Thyroid cancer was first described at the end of the eighteenth cen tury. For one and a half centuries surgery remained the only effective therapeutic option for this cancer, until in 1946 radioiodine therapy was performed for the first time. Radioiodine therapy was brought to Germany 4 years later, in 1950. In the intervening 50 years, the use of iodine-131 has proved able to cure the cancer and its metastases. Per cutaneous radiation therapy had been added to the therapeutic ar mamentarium, but even now there is heated debate as to its potential. Suppressive 1-thyroxine supplement is a prerequisite for successful treatment, while cytotoxic drugs are mainly used for palliation. During the past 10 years, various new diagnostic and therapeutic approaches have been introduced. High-dose radioiodine therapy as well as redifferentiation therapy with retinoic acid seem beneficial. Diagnostic procedures such as magnetic resonance imaging (MRI), positron emission tomography (PET), as well as isonitriles (MIBI) 201 and thallium ( Tl), have proved useful for the follow-up of thyroid cancer. Two special issues are also discussed in this book. Iodine supple mentation in areas of iodine deficiency has led to a change in pathol ogy insofar as papillary thyroid cancer (with a better prognosis) has become more frequent than follicular carcinoma. A special chapter is dedicated to thyroid cancer in Chernobyl children |
Beschreibung: | 1 Online-Ressource (XX, 301 p) |
ISBN: | 9783662046104 |
DOI: | 10.1007/978-3-662-04610-4 |
Internformat
MARC
LEADER | 00000nmm a2200000zc 4500 | ||
---|---|---|---|
001 | BV046147354 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | cr|uuu---uuuuu | ||
008 | 190905s2001 |||| o||u| ||||||eng d | ||
020 | |a 9783662046104 |9 978-3-662-04610-4 | ||
024 | 7 | |a 10.1007/978-3-662-04610-4 |2 doi | |
035 | |a (ZDB-2-SME)978-3-662-04610-4 | ||
035 | |a (OCoLC)1119019373 | ||
035 | |a (DE-599)BVBBV046147354 | ||
040 | |a DE-604 |b ger |e aacr | ||
041 | 0 | |a eng | |
049 | |a DE-355 | ||
082 | 0 | |a 616.994 |2 23 | |
084 | |a XH 6253 |0 (DE-625)152926:13132 |2 rvk | ||
245 | 1 | 0 | |a Thyroid Cancer |c edited by H.-J. Biersack, F. Grünwald |
264 | 1 | |a Berlin, Heidelberg |b Springer Berlin Heidelberg |c 2001 | |
300 | |a 1 Online-Ressource (XX, 301 p) | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
520 | |a Thyroid cancer was first described at the end of the eighteenth cen tury. For one and a half centuries surgery remained the only effective therapeutic option for this cancer, until in 1946 radioiodine therapy was performed for the first time. Radioiodine therapy was brought to Germany 4 years later, in 1950. In the intervening 50 years, the use of iodine-131 has proved able to cure the cancer and its metastases. Per cutaneous radiation therapy had been added to the therapeutic ar mamentarium, but even now there is heated debate as to its potential. Suppressive 1-thyroxine supplement is a prerequisite for successful treatment, while cytotoxic drugs are mainly used for palliation. During the past 10 years, various new diagnostic and therapeutic approaches have been introduced. High-dose radioiodine therapy as well as redifferentiation therapy with retinoic acid seem beneficial. Diagnostic procedures such as magnetic resonance imaging (MRI), positron emission tomography (PET), as well as isonitriles (MIBI) 201 and thallium ( Tl), have proved useful for the follow-up of thyroid cancer. Two special issues are also discussed in this book. Iodine supple mentation in areas of iodine deficiency has led to a change in pathol ogy insofar as papillary thyroid cancer (with a better prognosis) has become more frequent than follicular carcinoma. A special chapter is dedicated to thyroid cancer in Chernobyl children | ||
650 | 4 | |a Oncology | |
650 | 4 | |a Nuclear Medicine | |
650 | 4 | |a Endocrinology | |
650 | 4 | |a Oncology | |
650 | 4 | |a Nuclear medicine | |
650 | 4 | |a Endocrinology | |
650 | 0 | 7 | |a Schilddrüsenkrebs |0 (DE-588)4140890-1 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
689 | 0 | 0 | |a Schilddrüsenkrebs |0 (DE-588)4140890-1 |D s |
689 | 0 | |5 DE-604 | |
700 | 1 | |a Biersack, H.-J. |4 edt | |
700 | 1 | |a Grünwald, F. |4 edt | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783662046128 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783662046111 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783540413905 |
856 | 4 | 0 | |u https://doi.org/10.1007/978-3-662-04610-4 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
912 | |a ZDB-2-SME | ||
940 | 1 | |q ZDB-2-SME_1990/2004 | |
999 | |a oai:aleph.bib-bvb.de:BVB01-031527539 | ||
966 | e | |u https://doi.org/10.1007/978-3-662-04610-4 |l UBR01 |p ZDB-2-SME |q ZDB-2-SME_1990/2004 |x Verlag |3 Volltext |
Datensatz im Suchindex
_version_ | 1804180486618087424 |
---|---|
any_adam_object | |
author2 | Biersack, H.-J Grünwald, F. |
author2_role | edt edt |
author2_variant | h j b hjb f g fg |
author_facet | Biersack, H.-J Grünwald, F. |
building | Verbundindex |
bvnumber | BV046147354 |
classification_rvk | XH 6253 |
collection | ZDB-2-SME |
ctrlnum | (ZDB-2-SME)978-3-662-04610-4 (OCoLC)1119019373 (DE-599)BVBBV046147354 |
dewey-full | 616.994 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 616 - Diseases |
dewey-raw | 616.994 |
dewey-search | 616.994 |
dewey-sort | 3616.994 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
doi_str_mv | 10.1007/978-3-662-04610-4 |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03273nmm a2200529zc 4500</leader><controlfield tag="001">BV046147354</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190905s2001 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783662046104</subfield><subfield code="9">978-3-662-04610-4</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-3-662-04610-4</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SME)978-3-662-04610-4</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1119019373</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046147354</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.994</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XH 6253</subfield><subfield code="0">(DE-625)152926:13132</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Thyroid Cancer</subfield><subfield code="c">edited by H.-J. Biersack, F. Grünwald</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Berlin, Heidelberg</subfield><subfield code="b">Springer Berlin Heidelberg</subfield><subfield code="c">2001</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XX, 301 p)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Thyroid cancer was first described at the end of the eighteenth cen tury. For one and a half centuries surgery remained the only effective therapeutic option for this cancer, until in 1946 radioiodine therapy was performed for the first time. Radioiodine therapy was brought to Germany 4 years later, in 1950. In the intervening 50 years, the use of iodine-131 has proved able to cure the cancer and its metastases. Per cutaneous radiation therapy had been added to the therapeutic ar mamentarium, but even now there is heated debate as to its potential. Suppressive 1-thyroxine supplement is a prerequisite for successful treatment, while cytotoxic drugs are mainly used for palliation. During the past 10 years, various new diagnostic and therapeutic approaches have been introduced. High-dose radioiodine therapy as well as redifferentiation therapy with retinoic acid seem beneficial. Diagnostic procedures such as magnetic resonance imaging (MRI), positron emission tomography (PET), as well as isonitriles (MIBI) 201 and thallium ( Tl), have proved useful for the follow-up of thyroid cancer. Two special issues are also discussed in this book. Iodine supple mentation in areas of iodine deficiency has led to a change in pathol ogy insofar as papillary thyroid cancer (with a better prognosis) has become more frequent than follicular carcinoma. A special chapter is dedicated to thyroid cancer in Chernobyl children</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oncology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nuclear Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Endocrinology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oncology </subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nuclear medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Endocrinology</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Schilddrüsenkrebs</subfield><subfield code="0">(DE-588)4140890-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Schilddrüsenkrebs</subfield><subfield code="0">(DE-588)4140890-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Biersack, H.-J.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Grünwald, F.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783662046128</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783662046111</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783540413905</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-3-662-04610-4</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_1990/2004</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031527539</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-3-662-04610-4</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SME</subfield><subfield code="q">ZDB-2-SME_1990/2004</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
genre_facet | Aufsatzsammlung |
id | DE-604.BV046147354 |
illustrated | Not Illustrated |
indexdate | 2024-07-10T08:36:32Z |
institution | BVB |
isbn | 9783662046104 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031527539 |
oclc_num | 1119019373 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR |
owner_facet | DE-355 DE-BY-UBR |
physical | 1 Online-Ressource (XX, 301 p) |
psigel | ZDB-2-SME ZDB-2-SME_1990/2004 ZDB-2-SME ZDB-2-SME_1990/2004 |
publishDate | 2001 |
publishDateSearch | 2001 |
publishDateSort | 2001 |
publisher | Springer Berlin Heidelberg |
record_format | marc |
spelling | Thyroid Cancer edited by H.-J. Biersack, F. Grünwald Berlin, Heidelberg Springer Berlin Heidelberg 2001 1 Online-Ressource (XX, 301 p) txt rdacontent c rdamedia cr rdacarrier Thyroid cancer was first described at the end of the eighteenth cen tury. For one and a half centuries surgery remained the only effective therapeutic option for this cancer, until in 1946 radioiodine therapy was performed for the first time. Radioiodine therapy was brought to Germany 4 years later, in 1950. In the intervening 50 years, the use of iodine-131 has proved able to cure the cancer and its metastases. Per cutaneous radiation therapy had been added to the therapeutic ar mamentarium, but even now there is heated debate as to its potential. Suppressive 1-thyroxine supplement is a prerequisite for successful treatment, while cytotoxic drugs are mainly used for palliation. During the past 10 years, various new diagnostic and therapeutic approaches have been introduced. High-dose radioiodine therapy as well as redifferentiation therapy with retinoic acid seem beneficial. Diagnostic procedures such as magnetic resonance imaging (MRI), positron emission tomography (PET), as well as isonitriles (MIBI) 201 and thallium ( Tl), have proved useful for the follow-up of thyroid cancer. Two special issues are also discussed in this book. Iodine supple mentation in areas of iodine deficiency has led to a change in pathol ogy insofar as papillary thyroid cancer (with a better prognosis) has become more frequent than follicular carcinoma. A special chapter is dedicated to thyroid cancer in Chernobyl children Oncology Nuclear Medicine Endocrinology Oncology Nuclear medicine Schilddrüsenkrebs (DE-588)4140890-1 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content Schilddrüsenkrebs (DE-588)4140890-1 s DE-604 Biersack, H.-J. edt Grünwald, F. edt Erscheint auch als Druck-Ausgabe 9783662046128 Erscheint auch als Druck-Ausgabe 9783662046111 Erscheint auch als Druck-Ausgabe 9783540413905 https://doi.org/10.1007/978-3-662-04610-4 Verlag URL des Erstveröffentlichers Volltext |
spellingShingle | Thyroid Cancer Oncology Nuclear Medicine Endocrinology Oncology Nuclear medicine Schilddrüsenkrebs (DE-588)4140890-1 gnd |
subject_GND | (DE-588)4140890-1 (DE-588)4143413-4 |
title | Thyroid Cancer |
title_auth | Thyroid Cancer |
title_exact_search | Thyroid Cancer |
title_full | Thyroid Cancer edited by H.-J. Biersack, F. Grünwald |
title_fullStr | Thyroid Cancer edited by H.-J. Biersack, F. Grünwald |
title_full_unstemmed | Thyroid Cancer edited by H.-J. Biersack, F. Grünwald |
title_short | Thyroid Cancer |
title_sort | thyroid cancer |
topic | Oncology Nuclear Medicine Endocrinology Oncology Nuclear medicine Schilddrüsenkrebs (DE-588)4140890-1 gnd |
topic_facet | Oncology Nuclear Medicine Endocrinology Oncology Nuclear medicine Schilddrüsenkrebs Aufsatzsammlung |
url | https://doi.org/10.1007/978-3-662-04610-4 |
work_keys_str_mv | AT biersackhj thyroidcancer AT grunwaldf thyroidcancer |